Our work improves health and lifestyle self-monitoring through measurably better sensors. We partner with healthcare product and wearable technology manufacturers to improve the accuracy and sensitivity of their sensors, helping them to make products that improve lives.
We work closely with our partners to help them build better products and gain a competitive edge. The projects we deliver are all different depending on what is needed, so we work to understand the requirements of our partners and to tailor our process accordingly. A typical project can last for 10 months, starting with initial feasibility studies, running through proof-of-concept and upscaling phases, before final delivery and evaluation.
Nanoflex operates from the prestigious Sci-Tech Daresbury Campus. It raised external investment in 2012 and has since this time continued to grow. The company has an experienced board supported by a strong management team.
As Chairman of the Board of Directors, David’s role is to lead the executive and oversee the strategic direction of the company. David’s early career was spent at AstraZeneca, where he was involved in the development of diagnostic devices and was a founder of molecular diagnostics company DxS which was sold to Qiagen. He holds non-executive positions with a number of early stage technology companies.
Neville’s primary role within the company is to guide the strategic direction of the company and to support the business to business partnerships. Neville’s background is in industrial research, development and exploitation of sensors and instrumentation. He has been responsible for the formation of a number of companies and overseen their growth over the last 20 years.
Amy is responsible for the operational management of Nanoflex and for the management of its intellectual property. Amy’s career has revolved around the exploitation of intellectual property both in the SME and University sectors. She has over 20 years’ experience of patent licensing and of bringing new products to market. She has worked in sectors as diverse as advanced materials, biosensors and product engineering.
John is responsible for financial management and corporate planning at Nanoflex. John has extensive executive and non-executive main board experience with a range of companies, notably the LGC Group. John was a key member of the management buyout team of LGC and its board as the company expanded both within the UK and internationally to become a major player in the field. He also has experience of working in the public and not-for-profit sectors.
Robert’s main roles are development of new business and strategic partnerships. Robert’s background is in product and market development where he has spent the last 20 years working across the healthcare technologies sector. Prior to joining Nanoflex, Robert served as Business Development Manager at Medtronic and earlier Coviden with responsibilities for generating growth through strategic licensing deals within EMEA.
As Principal Scientist Marcus is responsible for the R&D of NanoFlex’s electrochemical biosensors; from developing the sensor fabrication processes to project management and delivery of sensors to our customer’s application requirements. Marcus has over 25 years’ experience developing new analytical measurements for the bio- and surface science area and in working with customers globally to support their research and development requirements.
Nanoflex is a small but fast-growing sci-tech company. We’re looking for bright and ambitious individuals to help us expand.
We’re after talented scientists, ideally with a background in sensors. But we also have roles in operations, marketing and business development.